Allostery Investments LP Portfolio Holdings

Allostery Investments LP

  • $95.7 Billion
  • Q4 2024

Allostery Investments LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $95.7 Billion distributed in 40 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Centessa Pharmaceuticals PLC with a value of $4.77B, Evolus, Inc. with a value of $4.76B, Apogee Therapeutics Inc with a value of $4.53B, Abivax Sa with a value of $4.33B, and Kal Vista Pharmaceuticals, Inc. with a value of $4.06B.

Examining the 13F form we can see an increase of $95.7B in the current position value.

Allostery Investments LP is based out at Stamford, CT

Below you can find more details about Allostery Investments LP portfolio as well as his latest detailed transactions.

Portfolio value $95.7 Billion
Healthcare: $41.4 Billion
ETFs: $37.3 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 40
  • Current Value $95.7 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 30 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Allostery Investments LP Portfolio

Follow Allostery Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allostery Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Allostery Investments LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email